OU Medical Center Laboratory

Oklahoma City, Oklahoma 73104-5047

0 studies enrolling now · 2 studies all time

What they study most

Ductal Carcinoma In Situ, Ovarian Cancer

Studies at this site

• Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer — Completed
• Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) — Status unconfirmed